Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00873171 · ClinicalTrials.gov registry record
Osteopathic Manipulation Therapy in the Treatment of Interstitial Cystitis
A clinical trial, sponsored by CAMC Health System.
- Completed
- Registry status
- 24
- Enrollment target
NCT00873171: Completed study, sponsored by CAMC Health System.
NCT00873171 is a clinical trial that has completed, run by CAMC Health System. The registered enrollment target is 24 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00873171 has completed, sponsored by CAMC Health System.
- COMPLETED
- Registry status
- 24 participants
- Enrollment target
Study Summary
As a safe and noninvasive method of treatment, the intent of the study is to show that Osteopathic manipulation therapy is a beneficial treatment for the aggravating bladder symptoms seen in all patients with interstitial cystitis.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2009-01 |
| Est. Completion | 2009-11 |
What the finished NCT00873171 record still lists
NCT00873171 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 24 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT00873171 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00873171 about?
NCT00873171 is a clinical study titled "Osteopathic Manipulation Therapy in the Treatment of Interstitial Cystitis". As a safe and noninvasive method of treatment, the intent of the study is to show that Osteopathic manipulation therapy is a beneficial treatment for the aggravating bladder symptoms seen in all patients with interstitial cystitis.
What is the current status of trial NCT00873171?
This trial is currently completed. The enrollment target is 24 participants. The study started on 2009-01. Estimated completion is 2009-11.
Who is sponsoring clinical trial NCT00873171?
This trial is sponsored by CAMC Health System, which has 28 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02331979 · 24 participants · NA
Improving Bladder Function in SCI by Neuromodulation
- NCT03096197 · 24 participants · NA
Exoskeleton and Spinal Cord Stimulation for SCI
- NCT03223922 · 24 participants · NA
Neurocognitive Functioning With Genu-Sparing Whole Brain Radiation Therapy for Brain Metastases
- NCT03326921 · 24 participants · Phase 1
HA-1 T TCR T Cell Immunotherapy for the Treatment of Patients With Relapsed or Refractory Acute Leukemia After Donor Stem Cell Transplant
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia